Skip to main content
main-content

Devices and technology

05-24-2017 | Artificial pancreas systems | News

Meta-analysis supports artificial pancreas superiority over pumps

Artificial pancreas systems increase time in blood glucose target range by nearly 3 hours per day compared with conventional pump therapy in outpatients with type 1 diabetes, meta-analysis data show.

Source:

Lancet Diabetes Endocrinol 2017; Advance online publication

04-11-2017 | Flash glucose monitoring | Article

Diabetes Therapy

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes

The authors find that use of flash glucose-sensing technology for glycemic management in patients with type 2 diabetes treated by insulin was associated with a sustained reduction in hypoglycemia and safely and effectively replaced self-monitoring of blood glucose.

Haak T et al. Diabetes Ther 2017. doi:10.1007/s13300-017-0255-6

04-10-2017 | Continuous glucose monitoring | News

CGM could improve quality of life in patients with type 1 diabetes

Continuous glucose monitoring is associated with improvements in diabetes-specific quality of life compared with self-monitoring among patients with type 1 diabetes who use multiple daily insulin injections, study results suggest.

Source:

Diabetes Care 2017; Advance online publication

04-07-2017 | Hypoglycemia | News

Predictive system reduces hypoglycemia burden in children with type 1 diabetes

Research suggests that a predictive low-glucose management system significantly reduces hypoglycemic events in children and adolescents with type 1 diabetes.

Source:

Diabetes Care 2017; Advance online publication

03-31-2017 | Insulin pumps | News

Insulin pumps do not boost education effects on glycemic control

Research shows that switching to an insulin pump does not improve glycemic control in patients referred to an educational program after struggling to control their type 1 diabetes with multiple daily injections.

Source:

BMJ 2017; 356: j1285

03-21-2017 | Adolescents | Feature | Article

Adolescents: A challenging age group

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.

03-04-2017 | Injection pens | Article

Diabetes Therapy

Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education

Truong et al. discuss three patient cases in which errors in insulin pen technique and administration negatively impacted their diabetes control and could have resulted in more serious health issues.

Truong TH et al. Diabetes Ther 2017;8:221-226. doi:10.1007/s13300-017-0242-y

03-03-2017 | Artificial pancreas systems | Hot topic review | Article

The artificial pancreas: Potential to transform diabetes care

medwireNews provides an overview of artificial pancreas systems, and talks to Professor Richard Bergenstal about their potential for treating type 1 diabetes.

02-17-2017 | Continuous glucose monitoring | News

Findings support standalone use of CGM in well-controlled type 1 diabetes

Results of a randomized trial suggest that continuous glucose monitoring can be used without regular confirmatory blood glucose monitoring among adult insulin pump users with well-controlled type 1 diabetes.

Source:

Diabetes Care 2017; Advance online publication

01-24-2017 | Continuous glucose monitoring | News

CGM could aid glycemic control with multiple daily insulin injections

Two clinical trials published in JAMA show that continuous glucose monitoring can improve glycemic control in patients with type 1 diabetes who take insulin by means of multiple daily injections.

Source:

JAMA 2017; 317: 363–364, 371–378, 379–387

image credits